2-(3-Indolyl)acetamides and their oxazoline analogues: Anticancer SAR study

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Previous 2-aryl-2-(3-indolyl)acetohydroxamates showed limited efficacy against melanoma in vivo.
• Metabolic instability, specifically glucuronidation of the N-hydroxyl group, was identified as a key limitation.

Purpose of the Study:

• To design and synthesize novel analogues lacking the N-hydroxyl group to overcome metabolic liabilities.
• To investigate the structure-activity relationships (SAR) of 2-aryl-2-(3-indolyl)acetamides and oxazoline derivatives against melanoma.

Main Methods:

• Synthesis of 2-aryl-2-(3-indolyl)acetamides and corresponding oxazoline derivatives.
• Evaluation of in vitro potency using GI50 values.
• Structure-activity relationship analysis to identify key structural features for activity.

Main Results:

• The 2-naphthyl group at the C-2 position of the indole was optimal for the amide series.
• The tetralin moiety at the same position was favorable for the oxazoline series.
• Three amide compounds exhibited potent in vitro activity with GI50 values ranging from 0.2-0.3 µM.

Conclusions:

• The N-hydroxyl group is not required for high in vitro potency in this series of melanoma agents.
• Optimized amide and oxazoline derivatives represent promising leads for further melanoma drug development.